GS-5816
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GS-5816, covering 2019-02-27 to 2020-03-19. Get the full timeline:
Most recent: Clinical Trial Update: Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816 [Phase 2]